chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a 69 year old female patient referring to herself. The patient was allergic to preservatives. There was no medical history or concomitant medication. On 16-JUL-2017, the patient was vaccinated with ZOSTAVAX (dose, lot# and expiration date unknown) subcutaneously for prophylaxis. On 19-JUL-2017 (also reported as 72 hours later), the patient broke out with a "very bad rash on her hands, feet and in her mouth". The patient thought ZOSTAVAX might contain preservatives, which she was allergic to and that was the reason for getting the rash. The patient had to go to the emergency room where she was treated with prednisone (a week's supply) and other unspecified medications. The patient was met at the emergency room by her physician, an allergist, who confirmed that the patient did not have shingles. No lab diagnostics/studies were performed. The outcome of the events was reported as recovering. Upon internal review, the event of rash and treated with prednisone was determined to be medically significant.
Immediately after the shot -- Tingling & loss of feeling in my arms & legs, lightheaded Persistent leg pain, body/joint aches, fatigue, and headaches.  Both arms are stiff & heavy 3 weeks afterwards, and sometimes click & pop when moving them around.  Also developed red spots (hives?) throughout my body & legs up until my second shot. The rash seem to get worse after second shot
Very itchy; Disorientated; Dizzy; Nauseous; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 09Apr2021 at 15:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included peptic duodenitis, hip impingement, fructose sensitivity, gluten sensitivity, dairy sensitivity, sulfa allergy and latex allergy. Concomitant medications included esomeprazole (NEXIUM), tramadol (MANUFACTURER UNKNOWN) and acetaminophen (MANUFACTURER UNKNOWN) all taken for unknown indications and since unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 09Apr2021 at about 21:00, the patient got very itchy, quite disorientated, dizzy and nauseous. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events itchy, disoriented, dizziness and nauseous was resolved with sequelae on 10Apr2021 at 06:00.   No follow-up attempts are needed. No further information is expected.
tenderness at the site of injection; developed a rash on the same arm where the injection was; sore; Allergic reaction; had little bumps on it; it is kind of irritated; This is a spontaneous report from a contactable consumer (patient herself). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot number was not reported), via an unspecified route of administration on 18Feb2021 as dose 1, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced an allergic reaction to the Pfizer COVID-19 vaccine. She reported that she had the Pfizer COVID-19 vaccine injection and was a little sore, and allergic reaction area had little bumps on it; since then there are more bumps on it and it is kind of irritated. She called to ask what to do or to put on the allergic reaction. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Gout; This is a spontaneous report from a Pfizer-sponsored program. A contactable female consumer (patient herself) of (Age: 68; Unit: Unspecified) reported that she received BNT162B2 (BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection) via unspecified route of administration, on unspecified date as dose 1, single for COVID-19 immunization. The patient medical history was not reported. The patient concomitant medications included CEPHALEXIN [CEFALEXIN] and COLCHICINE. She stated that, she received first vaccination 4 weeks ago, and was due for second dose but she was taking medications for gout. She took a methyl prednisolone dose pack which she finished a week ago, cephalexin that she just finished last night, and colchicine 0.6 mg one twice daily, that she finished yesterday as well. She was on Methyl Prednisolone and will finish it on Sunday. She was scheduled to take 2nd dose of vaccine on Tuesday and she was wondering if the medication will affect the vaccine On unspecified date, the patient received 1st dose of Covid vaccine and then developed gout. Therapeutic measures were taken as a result of event and treatment included with took a methyl prednisolone dose pack. The outcome of event was unknown   No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
within minutes felt an intense systemic response.  broke out in a sweat  clammy  sweat above upper lip  tingle/prickly feeling over body in fingers and toes dizzy  heart palps  gumby/jelly like limbs face muscles around mouth affected eye floaters splitting headache that started at base of skull and wrapped around to top of head and temples As response progressed extremities started to tremble teeth chattered fatigue  nausea  4-8 in the evening (over 24 hrs later)  intense sweating  difficulty swallowing brain fog
Had the shot about 12:30pm.  By 6pm I had a fever (101.5), chills, very sore arm, and was very tired.  Lasted all night and most of the next day.  Fever finally "broke" about 11:00pm (about 34 hours after the shot).  Tired  and arm was still painful.  Today my upper arm is still sore, but much less than it was in the 2 days after the shot.  Took a few Extra Strength Tylenols over the 2 days.
I received the 1st and 2nd doses of the COVID vaccine of Moderna. Went for the booster due to having cancer and receiving chemo and radiation and being immunocompromised. Filled it paperwork selected which vaccine I had gotten and present vaccination card to pharmacist. My daughter also got her 3rd dose and was with me. Pharmacist gave me injection then my daughter. He went to fill out our cards and saw mine then stated to my daughter ?Oops I didn?t see her card and realize that she got the Moderna vaccine, I saw your car and thought you both got the same vaccine.? ?Well I can?t take it back out of her?. This is a medication error and I don?t know how that?s gonna affect me or if I?ll build up antibodies and be protective for the next year until the next booster. Something needs done.
My shoulder began hurting around 2 weeks after my first COVID vaccination and has not stopped hurting. First vaccination was on April 8th. Shoulder began hurting extremely on or around April 18th. Still had my follow up pfizer vaccination on April 29th. It's May 10th and my should is still extremely sore/tender. Tylenol and Advil doesn't relieve the pain. Ice helps temporarily.
I noticed that my face had a rash and I started to feel I was breaking out in hives on my body because I began to itch. I called the advice nurse around October 7, 2014 to explain my symptoms and she suggested hydrocortisone cream and benadryl to no avail.
Legs swelled up after second shot / Legs swelling comes and goes after second shot / Leg swelling has not gone down completely after second shot; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Legs swelled up after second shot / Legs swelling comes and goes after second shot / Leg swelling has not gone down completely after second shot) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007B21A and 022M20A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to metals.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Mar-2021, the patient experienced PERIPHERAL SWELLING (Legs swelled up after second shot / Legs swelling comes and goes after second shot / Leg swelling has not gone down completely after second shot). At the time of the report, PERIPHERAL SWELLING (Legs swelled up after second shot / Legs swelling comes and goes after second shot / Leg swelling has not gone down completely after second shot) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment medications were provided.  Patient visited several doctors. one told to see a psychiatrist and the other 2 told her to put cream on it. Patient has an appointment with her regular clinic where the first 2 doses were received.
Midly confused, had trouble comprehending conversation and tracking the newspaper articles; Unusually tired.; Lethargic could scarcely function; Fell; This case was reported by a consumer and described the occurrence of lethargy in a 91-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (had 10 years before sever shingles) and shingles (had mild shingles last year). Concurrent medical conditions included blood pressure abnormal, vascular insufficiency and nerve pain (Taking Lyrica ). Concomitant products included pregabalin (Lyrica).   On 30th October 2019, the patient received the 1st dose of Shingrix. On 31st October 2019, 1 days after receiving Shingrix, the patient experienced lethargy and fall. On 1st November 2019, the patient experienced confusion and fatigue. On an unknown date, the outcome of the lethargy, fall, confusion and fatigue were unknown.   It was unknown if the reporter considered the lethargy, fall, confusion and fatigue to be related to Shingrix.  Additional details were provided as follows: The patient received dose of Shingrix in the late afternoon and experienced no ill effect tiil the reminder day. The next day after vaccination , the patient found herself so lethargic, could scarcely function. The patient took slept in until noon, took a four hour nap during the day. The patient was getting ready for bed felt and in less than twelve hours laterthe next morningshe felt again. The next day, the patient was mildly confused, had trouble comprehending conversation and tracking the newspaper articles, and continued to be unusually tired. The patient was alert and oriented, until was administered vaccine. It took until the third day after the immunization for her return to normal. Due to these side effects, the patient did not took 2nd dose of Shingrix. Till the time of reporting, the patient still recovering from fall and  could not risk another.
Vomited 5 times at school after receiving Menquadfi; Initial information received on 14-Apr-2022 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a 11 years old female patient who experienced vomited 5 times at school after receiving menquadfi while receiving vaccine MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE [MENQUADFI].   The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included HPV VACCINE (HPV VACCINE); and TETANUS VACCINE (TETANUS VACCINE).  On 14-Apr-2022, the patient received a  dose of suspect MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE lot U7249AA (expiry date 03-Nov-2024) via intramuscular route in the right deltoid for Immunization.  On 14-APR-2022 (latency: Same day) the patient developed a non-serious vomited 5 times at school after receiving menquadfi (vomiting) following the administration of MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE.  Action taken with MENINGOCOCCAL VACCINE (MENQUADFI) was not applicable.  It was not reported if the patient received a corrective treatment for the event (Vomited 5 times at school after receiving Menquadfi).  At time of reporting, the outcome was Unknown for the event vomited 5 times at school after receiving menquadfi.
Bruising from injection site up to shoulder; This is a spontaneous report from a contactable healthcare professional (reporting for himself).  A 55-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot number: EL3246), via an unspecified route of administration in the left arm on 09Jan2021 14:45 at a single dose for COVID-19 immunization.  Medical history included multiple sclerosis (MS).  Concomitant medication included lisinopril (MANUFACTURER UNKNOWN). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.  The patient experienced bruising from injection site up to shoulder on 10Jan2021.  The patient did not received treatment for the event.  The outcome of bruising from injection site up to shoulder was not recovered.
Severe pain and swelling under arm (same arm as vaccine); Severe pain and swelling under arm (same arm as vaccine); chills; fever; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 60 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 09Apr2021 (Lot number: EP6955) at the age of 60 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Allergies: Sulfa antibiotis" (unspecified if ongoing). There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 1 , Batch/Lot No: EN6204 , Location of injection: Arm Left), administration date: 21Mar2021, when the patient was 60 years old, for COVID-19 immunization, reaction(s): "No events after first vaccine". The following information was reported: PERIPHERAL SWELLING (non-serious), PAIN IN EXTREMITY (non-serious) all with onset 2021, outcome "unknown" and all described as "Severe pain and swelling under arm (same arm as vaccine)"; CHILLS (non-serious) with onset 2021, outcome "unknown", described as "chills"; PYREXIA (non-serious) with onset 2021, outcome "unknown", described as "fever".  Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. List of any other medications the patient did not received within 2 weeks of vaccination. Prior to vaccination, the patient did not diagnosed with COVID-19. Since the vaccination, the patient did not have been tested for COVID-19.   No follow-up attempts are possible. No further information is expected.
17 year old patient was immunized at a mass vaccination clinic but the minimum age is 18 years old.
pt recv vax & pt fell out of chair hit head & had a petite mal sz lasting 45sec;911 called pt transported to ER for eval BP 110/70 pulse for resp 16;
Approx 10 min after receiving vaccine- patient developed rash and hives on neck and chest with complaints of itchiness on R arm at vaccine site.  Also developed redness to right ear.  no respiratory difficulties noted.  Patient transported to ED for further evaluation and treatment
sore arm; bump on back of her head; swollen lymph nodes on the left side behind her ear; her scalp was itchy; she had a rash at the injection site; eventually she was diagnosed with an "all-over body rash"; hives were concentrated on her legs and scalps; lesser degree of hives on her back, abdomen, and arm; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (sore arm), MASS (bump on back of her head), LYMPHADENOPATHY (swollen lymph nodes on the left side behind her ear), PRURITUS (her scalp was itchy) and VACCINATION SITE RASH (she had a rash at the injection site) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for an unknown indication. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history provided). Concomitant products included MULTIVITAMIN & MINERAL, METOPROLOL and TOCOPHEROL (VITAMIN E FORMULA) for an unknown indication.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm), MASS (bump on back of her head), LYMPHADENOPATHY (swollen lymph nodes on the left side behind her ear), PRURITUS (her scalp was itchy), VACCINATION SITE RASH (she had a rash at the injection site), RASH (eventually she was diagnosed with an "all-over body rash"), URTICARIA (hives were concentrated on her legs and scalps) and URTICARIA (lesser degree of hives on her back, abdomen, and arm). At the time of the report, PAIN IN EXTREMITY (sore arm), MASS (bump on back of her head), LYMPHADENOPATHY (swollen lymph nodes on the left side behind her ear), PRURITUS (her scalp was itchy), VACCINATION SITE RASH (she had a rash at the injection site), RASH (eventually she was diagnosed with an "all-over body rash"), URTICARIA (hives were concentrated on her legs and scalps) and URTICARIA (lesser degree of hives on her back, abdomen, and arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient reported that the doctor prescribed her steroids and cetirizine (Zyrtec) to treat the events.
Pt initially contacted clinic describing shortness of breath present the night before, and no other symptoms. Pt advised to go to ED or call 911. Pt contacted today and he described his symptoms differently, specifically as: aprox 5 hours after COVID immunization, developed fever 102, sweating, loss of small and taste, diarrhea, fatigue beginning noc of immunization and gradually fading over ~3.5 days. Only residual Sx pt endorses at this time are diarrhea and fatigue. Pt given advice directly from Provider to go to emergency dept/call 911. Pt cont. to decline to attend emergency dept /urgent care of get COVID test, saying "I'll ride it out."
1st day-  started to have left arm pain, sore, heavy at around 6PM 2nd day - started at 5 am noted my left arm was swollen, still sore & painful,  having chills, headache muscle aches and later on having fever 99.8F-100.2F.  Took Tylenol  x 3. 3rd day - still having muscle aches and left arm pain & soreness. 4th day - still having  mild left arm pain.
Client fully vaccinated for COVID-19 and tested positive via PCR on 10/21/21. Client died on 11/14/2021 from COVID-19
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. The patient's relevant medical history, concomitant medications and past drug histories are unknown. On 09-DEC-2014 (also reported as "on unknown date") the patient was vaccinated with GARDASIL (dose, frequency and route of administration were not reported, lot # K005881, with expiration date 14-JUL-2007). On 09-DEC-2014 patient was given a GARDASIL that had been through a temperature excursion on this day and possibly a past temperature excursion. It was unknown if the GARDASIL was a first, second or third injection of the series. It was unknown if there was any relevant laboratory data. As of 09-DEC-2014 it was unknown if the patient will continue to receive GARDASIL and the outcome of giving the GARDASIL with a temperature excursion was unknown. This is one of several reports received from the same reporter. Additional information has been requested.
Patient received the 12 and up bivalent booster for pfizer and he is only 9 . He did not have a reaction to the vaccine
Information has been received from a physician who heard that a female who was vaccinated with the first dose of GARDASIL for prevention of HPV, at her physician's office experienced swelling of the lips and rash. The patient's symptoms resolved. The patient sought medical attention. Additional information has been requested.
On 11/29/12 I was cold most of the day, the morning of 11/130/12 when I woke up I noticed what I thought might be bug bits on my right side torso under my breast and going around to my back on right side. I took Benadryl to see if it would go away but it didn't. I decided to go to the Dr. 12/4/12 and was told I have shingles and was put on Valacyclovir for 7 days.
Questionable beaten.  Fever, Vomit aded from med rec rec'd 12/22/2005/sr    Terms added from Discharge summary rec'd 01/20/2006: subarachnoid hemorrhage, anoxia, DM, retinal Hemorrhage, contusions, fractures./sr No additional terms added from Autopsy report rec'd 12/30/2005.
Student states, area is itchy and tender.  Area approx 6 by 8 mm and red, swollen and warm to touch.  No temperature.
Pt stated discomfort noted in L shoulder area 3-4 days after flu shot rec'd in L arm. Pt observed bruise in area near top of shoulder, but no swelling. States she experienced limited movement of L arm. Went to Dr 12/10/01 who diagnosed tendonitis and prescribed home exercises. Pt states now w/neck pain and states MD said this is related to the shoulder pain. Small flat purple discoloration seen today by me at top of L shoulder area.
Chicken pox like spots/spots broke out on his back/; Joint pain; rash has now turned into bumps/red rash with little bumps; red rash; Rash on back/ shoulder/chest/forehead/face/around eyes/nose; itching on back/shoulder/chest/forehead/face/hair was itching/overall itching; This case was reported by a consumer via call center representative and described the occurrence of rash in a 57-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included chickenpox and shingles.   On 20th November 2019, the patient received the 1st dose of Shingrix (intramuscular). On 27th November 2019, 7 days after receiving Shingrix, the patient experienced pruritus. On 4th December 2019, the patient experienced rash, varicella-like rash, joint pain, papular rash and red rash. On an unknown date, the outcome of the rash, pruritus, varicella-like rash, joint pain, papular rash and red rash were unknown.   It was unknown if the reporter considered the rash, pruritus, varicella-like rash, joint pain, papular rash and red rash to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix and around 1st week of December, he started experiencing rash and itching on back, shoulder, chest, forehead and face.The rash has turned into bumps and the itching was getting better.He also experienced chicken pox looking like spots on shoulder and back.They have not started spreading to the side of the body, and his buttock area. It was also starting to affect his eye. He breaks out and it clears up and comes back in another spot. He also experienced joint pain that lasted for about 3 weeks. He visited his doctor regarding his experience and was directed to contact his pharmacy. Around one week after the injection he started developing overall itching.  Around one week after the injection he started developing overall itching. About the second week he also developed rash, joint pain, spots broke out on his back, hair was itching, rash around his eye, chest and face, forehead and nose.The patient cannot use shampoo because it would set his symptoms on fire.The patient still had all the symptoms.Symptoms are not as bad, but he still had them. The reporter consented to follow up. No further details were provided.